COMMERZBANK AG (CBK.DE)       7.748  +0.03 (+0.34%)

7.748  +0.03 (+0.34%)

DE000CBK1001 - Common Stock


Fundamental Rating

4

Overall CBK gets a fundamental rating of 4 out of 10. We evaluated CBK against 26 industry peers in the Banks industry. CBK has a bad profitability rating. Also its financial health evaluation is rather negative. A decent growth rate in combination with a cheap valuation! Better keep an eye on CBK.




Profitability

Profitability Rating

1

The Piotroski-F score of CBK is 4.00. This is a neutral score and indicates average health and profitability for CBK.
CBK has a Return On Assets of 0.25%. This is below the industry average of 0.53%. 88% of the industry peers outperform CBK.

CBK has a Return On Equity of 4.66%. This is below the industry average of 10.32%. 92% of the industry peers outperform CBK.
CBK has a Profit Margin of 12.53%. This is below the industry average of 16.68%.
VS Industry

ROA (0.25%) VS Industry: 12% outperformed.

-0.21
21.87

ROE (4.66%) VS Industry: 8% outperformed.

2.48
23.42

Profit Margin (12.53%) VS Industry: 28% outperformed.

-12.44
97.95

Valuation

Valuation Rating

9

The Price/Earnings Ratio is 7.91, which indicates a rather cheap valuation of CBK.
The Forward Price/Earnings Ratio of 6.49 indicates a rather cheap valuation of CBK.
CBK's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the current price to the book value of CBK, it is valued rather cheaply. It is trading at 0.33 times its book value.
When comparing the price book ratio of CBK to the average industry price book ratio of 0.54, CBK is valued rather cheaply.
Compared to an average industry Price/Earning Ratio of 7.31, CBK is valued in line with its industry peers.
VS Industry

Price/Earnings (7.91) VS Industry: 45% outperformed.

12.43
1.61

Price/Book (0.33) VS Industry: 76% outperformed.

1.18
0.09

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 288.46% over the past year.
Based on estimates for the next 5 years, CBK will show a very strong growth in Earnings Per Share. The EPS will grow by 61.04% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
CBK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.64%.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Earnings Per Share has been growing slightly by 2.59% on average over the past 5 years.
CBK shows a decrease in Revenue. Measured over the last 5 years, the Revenue has been decreasing by -0.08% yearly.
Based on estimates for the next 5 years, CBK will show a small growth in Revenue. The Revenue will grow by 3.74% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.59% -28.36% 288.46% 280.54% 118.51% 86.12% 61.04%
Revenue-0.08% 3.59% 15.64% 13.36% 8.01% 6.11% 3.74%

Health

Health Rating

3

With a Debt to Equity ratio of 0.00, CBK is one of the better performing companies in its industry. It outperforms 100% of its industry peers.

The Piotroski-F score of CBK is 4.00. This is a neutral score and indicates average health and profitability for CBK.
VS Industry

Debt/Equity (0) VS Industry: 100% outperformed.

6.11
0.00

Dividend

Dividend Rating

0

No dividends for CBK!.

CBK Daily chart

COMMERZBANK AG7.748

FRA:CBK (12/2/2022, 7:00:00 PM)+0.03 (+0.34%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Banks
GICS Industry Banks
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners N/A
Market Cap 9.70B Analysts 75.38
Valuation
PE 7.91 Fwd PE 6.49
PEG (NY) 0.03 PEG (5Y) 3.05
P/S 0.88 P/B 0.33
EV/EBITDA N/A
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y 288.46% EPS 3Y -28.36%
EPS 5Y 2.59% EPS growth Q2Q -53.12%
EPS Next Y 280.54% EPS Next 2Y 118.51%
EPS Next 3Y 86.12% EPS Next 5Y 61.04%
Revenue growth 1Y 15.64% Revenue growth 3Y 3.59%
Revenue growth 5Y -0.08% Revenue growth Q2Q 29.43%
Revenue Next Year 13.36% Revenue Next 2Y 8.01%
Revenue Next 3Y 6.11% Revenue Next 5Y 3.74%
Health
Current Ratio N/A Quick Ratio N/A
Altman-Z N/A F-Score 4
Debt/Equity 0 WACC 6.96%
ROIC/WACC N/A
Profitability
ROA 0.25% ROE 4.66%
ROICexgc N/A ROIC N/A
PM 12.53% OM N/A
Asset Turnover 0.02

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the European

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the European

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the European

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the European